Navigation Links
Cancer Vaccines: From First-in-Class to Best-in-Class?
Date:4/9/2013

rgets 154
6.2.32 Receptor Signaling Protein Tyrosine Phosphatase Activity Targets 155
6.2.33 RNA-directed DNA Polymerase Activity Targets 156
6.2.34 Serine-type Peptidase Activity Targets 158
6.2.35 T Cell Receptor Activity Targets 161
6.2.36 Transcription Factor Activity Targets 164
6.2.37 Transcription Regulator Activity Targets 169
6.2.38 Translation Regulator Activity Targets 170
6.2.39 Transmembrane Receptor Activity Targets 171
6.2.40 Transmembrane Receptor Protein Tyrosine Kinase Activity Targets 173
6.2.41 Transporter Activity Targets 186
6.2.42 Other Targets 191
6.3 Mutation Profiles of Cancer Vaccine Drug Targets 201
6.3.1 Targets of Cancer Vaccine Drugs Present in the Cancer Gene Census and in the Catalogue of Somatic Mutations in Cancer 201
6.4 Target-Target Interactions among Identified Targets of Cancer Vaccine Drugs 205
6.5 Protein Expression Levels of Identified Targets of Cancer Vaccine Drugs 208
6.6 The Drug-Target Competitive Landscape 210
6.7 Pathway Assessment of Cancer Vaccine Drugs 214
6.7.1 Tools for Analysis of Cancer Pathways 215
6.7.2 Pathway Assessment 216
7 First-in-Class and Me-too Analysis of Cancer Vaccine Drugs 246
7.1 First-in-Class and Me-too in Marketed Drugs 249
7.2 First-in-Class and Me-too in Phase III Clinical Development 250
7.3 First-in-Class and Me-too in Phase II Clinical Development 252
7.4 First-in-Class and Me-too in Phase I Clinical Development 255
7.5 First-in-Class and Me-too in Preclinical Development 258
7.6 Drug Target Strategies of Suspended or Terminated Cancer Vaccine Drugs 261
8 Is First-in-Class the Best-in-Class? 263
8.1.1 Marketed 266
8.1.2 Phase III 269
8.1.3 Phase II 293
8.1.4 Phase I 325
8.1.5 Preclinical 339
8.1.6 Suspended 358
8.1.7 Ceased 359
9 Compound Strategies at Work: Competitive Benchmarking of Cancer Vaccine Drugs by Compound Strategy 387
9.1 Small Mole
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
2. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
3. Take the Skyhook Challenge and Help Beat Blood Cancer
4. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
5. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
6. Penn Medicines New Center For Personalized Diagnostics Unlocks Cancers Secrets
7. Cerulean Pharma to Present Data on CRLX101s HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
8. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
9. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
10. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
11. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- PharmaPoint: Type 1 Diabetes - Global Drug Forecast and ... (T1D) is an autoimmune disease that permanently destroys beta cells ... no longer produce insulin. Over the last 90 years, insulin ... treatment can be offered to a patient who is newly ... times of action - long-acting as well as short or ...
(Date:5/27/2015)... YORK , May 27, 2015 PharmaPoint: ... Forecast and Market Analysis to 2022 - Event-Driven Update ... dominated by generics and GlaxoSmithKline,s Benlysta is the only ... more than 50 years. Following Benlysta,s launch, patients, uptake ... price-tag Benlysta has managed to grow the lupus market ...
(Date:5/27/2015)... 27, 2015 ... announced the addition of the  "2015 Strategies ...  report to their offering. ... pertaining to the US NAT laboratory practice, ... social and technological trends with significant market ...
Breaking Medicine Technology:PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 2PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 3United States Nucleic Acid Testing Market Strategies 2015-2020 2
(Date:5/28/2015)... 2015 Sunshine Coast Health Center, ... Rehabilitation programs at http://www.sunshinecoasthealthcentre.ca , is proud ... outreach to the Toronto, Ontario, community. The company ... has enhanced its online location information for Toronto ... treatment center, we realize that addiction impacts family ...
(Date:5/28/2015)... Rochester, NY (PRWEB) May 28, 2015 JJ ... elected secretary of the New York Physical Therapy Association (NYPTA) ... has been an active member of the NYPTA. At ... member of the Neurology Section Research Committee and an abstract ... Chapter level, she has been a member of the Program ...
(Date:5/27/2015)... Throughout the past few months, Push to ... the validity and reliability of the Shaw Gait Assessment in ... Associate Professor in the Department of Physical Therapy at Seton ... The Shaw Gait Assessment is a free online tool, where ... GaitRite is considered the gold standard in providing information about ...
(Date:5/27/2015)... San Rafael, CA (PRWEB) May 27, 2015 ... Softball Camp director, Bree Nasti, the Adelphi University softball ... to the Divsion II Softball Championship since becoming a ... at 0-11, Adelphi University softball team turned it around ... Softball Championship. After defeating University of Central Missouri in ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 As the ... to buy health insurance under the Affordable Care Act ... School of Public Health, the RAND Corporation and Express ... from over a million initial enrollees. , The ... by Health Affairs and will also appear in the ...
Breaking Medicine News(10 mins):Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 2Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 3Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:US Sports Camps and Nike Softball Camps Congratulate the Adelphi University Softball Team 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 3Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 4
... obese people are discriminated against.,// ,There are signs in ... are not bashful about it either, according to sources from ... more difficult to convince them that they should lose weight. ... as 27.7% of the country’s children are overweight, while 13% ...
... will hold a beauty contest in which only HIV positive ... will be held in Russia on 1 December 2005, which ... girls will participate.// The contest has been named ‘Miss Positive-2005’. ... of the public with regard to the scourge, and also ...
... point out to two genes, both variant forms of a ... significant role in the smoking addiction.// The protein product of ... nicotine from the body. ,The two identified gene ... in the metabolism of nicotine, more specifically found to account ...
... to new research, elderly heart failure patients in United ... but lose that advantage over time.// ,Their study ... of Internal Medicine. ,Heart failure is the most ... older in both countries. ,The authors compared process ...
... Surgery remains the most effective treatment option for patients ... regarding the best way to treat a patient who ... surgery. //Infact very little surgical options are currently available ... the perseverant work of the researchers who have now ...
... that besides being really harsh on the ears, high-level noise ... the latest issue of the European Heart Journal // , ... increased risk of heart attack. ,Researchers from Charité ... 1998 and 2001 in 32 hospitals in Berlin. They compared ...
Cached Medicine News:Health News:Tendency To Smoke and Get Addicted Could Run In Families! 2Health News:Disparity In Survival Rates In US and Canadian heart Patients 2Health News:Novel Treatment Found To Prolong Survival Of Liver Cancer Patients 2Health News:Irritating Noise Increases Risk Of Heart Attacks 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: